Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Schwab US Dividend Equity ETF (SCHD) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance

Schwab US Dividend Equity ETFTrade
Vir Biotechnology Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Schwab US Dividend Equity ETF vs Vir Biotechnology Inc. Common Stock — how do they compare? Schwab US Dividend Equity ETF trades at $33.99 (market cap $111.61B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.76B). The key difference: Schwab US Dividend Equity ETF is far larger — about 63.4× Vir Biotechnology Inc. Common Stock's market cap, and Schwab US Dividend Equity ETF is more actively traded (22,238,193 versus 2,764,948). Which is the better fit depends on your goals — on Pluang, investors hold Schwab US Dividend Equity ETF for 64 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.

SCHDVIR
Market Cap
$111.61B$1.76B
Volume
22,238,1932,764,948
Sector
Broad Market / FactorHealth
52-Week High
$35.21$11.78
52-Week Low
$26.44$5.12
Typical Hold Time
64 Days0 Days
Enterprise Value
—$1.32B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Schwab US Dividend Equity ETF

SCHD trades at $33.37, up 0.33% with a bullish technical signal from moving averages. Recent news highlights SCHD outperforming the S&P 500 in 2026 and growing its dividend. The ETF's defensive dividend strategy faces scrutiny after missing gains from stocks like Broadcom due to its selection rules.

The outlook remains positive for income investors seeking quality dividend growth with lower risk through diversification. Key risks include interest rate sensitivity and the opportunity cost of excluded high-growth stocks. Current technical strength supports near-term stability.

Vir Biotechnology Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

SCHD
80% Buy20% Sell
Avg holding period · 64 Days
VIR
51% Buy49% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Schwab US Dividend Equity ETF

SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.

Read more on SCHD →

About Vir Biotechnology Inc. Common Stock

Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.

Read more on VIR →